Cargando…
Cyclosporine therapy during the COVID-19 pandemic
Autores principales: | Rudnicka, Lidia, Glowacka, Paulina, Goldust, Mohamad, Sikora, Mariusz, Sar-Pomian, Marta, Rakowska, Adriana, Samochocki, Zbigniew, Olszewska, Malgorzata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier on behalf of the American Academy of Dermatology, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196541/ https://www.ncbi.nlm.nih.gov/pubmed/32376422 http://dx.doi.org/10.1016/j.jaad.2020.04.153 |
Ejemplares similares
-
The Antiviral Properties of Cyclosporine. Focus on Coronavirus, Hepatitis C Virus, Influenza Virus, and Human Immunodeficiency Virus Infections
por: Glowacka, Paulina, et al.
Publicado: (2020) -
The Significance of Scalp Involvement in Pemphigus: A Literature Review
por: Sar-Pomian, Marta, et al.
Publicado: (2018) -
Cyclosporine With and Without Systemic Corticosteroids in Treatment of Alopecia Areata: A Systematic Review
por: Nowaczyk, Joanna, et al.
Publicado: (2020) -
The value of trichoscopy in the differential diagnosis of scalp lesions
in pemphigus vulgaris and pemphigus foliaceus
por: Sar-Pomian, Marta, et al.
Publicado: (2014) -
The Influence of Microbiome Dysbiosis and Bacterial Biofilms on Epidermal Barrier Function in Atopic Dermatitis—An Update
por: Blicharz, Leszek, et al.
Publicado: (2021)